An Indian-American scientist has engineered T-cells - a type of immune cells - to break the pancreatic cancer's physical and immunological walls using immunotherapy. In the tests conducted on mice with pancreatic tumours, the engineered T-cells killed those tumour cells over a 10-day period.
